Usana Health Sciences, Inc., a Utah-based nutritional, skincare and dietary products manufacturer, indicates in its recently filed 8-K that it has substantially completed an internal investigation into whether the expense reimbursement policy and other practices at its Chinese affiliate, BabyCare Ltd., were compliant with the Foreign Corrupt Practices Act. The company reports that it is cooperating with the DOJ and the SEC in their investigations of the matter.
February 5, 2019
DOJ and SEC investigating nutritional supplement maker for possible FCPA violations
Related by Topic
Ericsson states it will continue cooperating with DOJ and SEC as FCPA monitorship ends
June 3, 2024
News Alert
Argentinian national pleads guilty to money laundering conspiracy linked to Venezuelan government officials
May 20, 2024
News Alert
Florida jury convicts former Comptroller General of Ecuador in bribery and money laundering scheme
April 29, 2024
News Alert